Literature DB >> 22064914

Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)].

Nicola Margiotta1, Rosa Ranaldo, Francesco P Intini, Giovanni Natile.   

Abstract

Oxidative addition and reductive elimination are fundamental processes in transition-metal chemistry. New interest in this field has been generated by the exploitation of platinum(IV) complexes as antitumor drugs. The two extra ligands can be used to render these species more resistant to attack by biological nucleophiles compared to their platinum(II) counterparts, to anchor additional pharmacologically active moieties, or, finally, to target the drug to specific sites by conferring responsiveness to some type of chemotaxis. On the other hand, platinum(IV) species are considered to be prodrugs and to require reduction to Pt(II) to become active. Thus, reductive elimination promoted by biological reducing agents becomes an important issue and it too could be exploited for targeting purposes. In this paper, we investigated the oxidation step in more detail and shown that, independent of the solvent used, a solvent molecule assists the reaction by entering in a trans position with respect to the attacking oxidant. In the case of bifunctional solvent molecules, such as dimethylsulfoxide, both S- and O-coordinated species are formed, the latter being thermodynamically favored. The substitution of the axially coordinated solvent molecule by a free chloride ion is found to be quite slow in organic solvents, as well as in water. It is also shown that the intermediate solvato-species can be exploited for binding just one molecule of another substrate in the axial position. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064914     DOI: 10.1039/c1dt11232e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  5 in total

1.  Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.

Authors:  Timothy C Johnstone; Sarah M Alexander; Justin J Wilson; Stephen J Lippard
Journal:  Dalton Trans       Date:  2015-01-07       Impact factor: 4.390

Review 2.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

3.  A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.

Authors:  Hristo P Varbanov; Simone Göschl; Petra Heffeter; Sarah Theiner; Alexander Roller; Frank Jensen; Michael A Jakupec; Walter Berger; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2014-07-30       Impact factor: 7.446

4.  Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position.

Authors:  Salvatore Savino; Nunzio Denora; Rosa Maria Iacobazzi; Letizia Porcelli; Amalia Azzariti; Giovanni Natile; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2016-06-25       Impact factor: 5.923

5.  Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.

Authors:  Paride Papadia; Katia Micoli; Alessandra Barbanente; Nicoletta Ditaranto; James D Hoeschele; Giovanni Natile; Cristina Marzano; Valentina Gandin; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.